CFM
FLNA

Catalyst Funds Management’s Filana Therapeutics FLNA Stock Holding History

Catalyst Funds Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.6K Buy
+18,100
New +$37.3K 0.01% 562
2025
Q4 		– Sell
-44,500
Closed -$129K – 540
2025
Q3 		$129K Buy
44,500
+25,700
+137% +$59.1K 0.02% 449
2025
Q2 		$34K Buy
+18,800
New +$33.5K 0.01% 398
2024
Q2 		– Sell
-300
Closed -$6.09K – 1547
2024
Q1 		$6.09K Buy
+300
New +$6.91K ﹤0.01% 957

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Catalyst Funds Management's FLNA Position: Q1 2026 in Review

Catalyst Funds Management opened a new position in Filana Therapeutics (FLNA) in Q1 2026: 18,100 shares worth $30.6K. The stake represents 0.01% of the portfolio and ranks #562 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in FLNA as recently as Q3 2025.

Catalyst Funds Management first reported a position in FLNA in Q1 2024 and has held it in 4 quarters since. The position peaked at $129K in Q3 2025. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Catalyst Funds Management held 18,100 shares of Filana Therapeutics worth $30.6K as of Q1 2026.
  • Filana Therapeutics was a new Catalyst Funds Management position in Q1 2026.
  • Filana Therapeutics made up 0.01% of Catalyst Funds Management's portfolio in Q1 2026, its #562 holding.
  • Catalyst Funds Management first reported a position in Filana Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Catalyst Funds Management's Filana Therapeutics position peaked at $129K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.